+467.0%
MRNA vs GPN
+5.1%
+461.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GPN | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | 0.0% | +5.4% | +5.4% |
| 7D | -1.1% | -4.3% | +3.2% | +0.8% |
| 30D | +126.1% | 0.0% | +126.1% | +127.2% |
| 3M | +190.0% | +35.8% | +154.2% | +164.9% |
| 6M | +157.2% | +22.0% | +135.2% | +140.6% |
| YTD | +388.2% | +15.2% | +373.0% | +358.6% |
| 1Y | +467.0% | +3.5% | +463.5% | +463.4% |
| All | +467.0% | +5.1% | +461.9% | +463.4% |
Cumulative growth
Daily Returns
Daily percentage return beside GPN.
Daily Out/Under-Performance
Portfolio return minus GPN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GPN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GPN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling